Tags

Type your tag names separated by a space and hit enter

An overview of treatment of overactive bladder syndrome in women.
J Obstet Gynaecol. 2012 Apr; 32(3):217-21.JO

Abstract

Overactive bladder syndrome (OAB) is a common, often under-reported and under-treated condition that significantly affects the quality of life (QoL) of the sufferer and is associated with enormous related costs. Treatments options for OAB include lifestyle modifications, behavioural therapy, pharmacotherapy, neuromodulation, Botulinum toxin therapy and surgical interventions. For this paper, the Embase, Cochrane and Medline databases were searched for studies relating to the treatment options for OAB with (urge urinary incontinence) UUI from 1975 to 2010. Studies were also obtained from references of published reviews. Search terms used for retrieval were: overactive bladder syndrome, urge urinary incontinence, anticholinergics, Botulinum toxin A, sacral neuromodulation and clam bladder augmentation. The aim of this paper is to provide an overview of the treatment options currently available for women with OAB.

Authors+Show Affiliations

Department of Obstetrics and Gynaecology, St Mary's Hospital, Newport, Isle of Wight, UK. drallahdin@hotmail.co.ukNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22369391

Citation

Allahdin, S, and N Oo. "An Overview of Treatment of Overactive Bladder Syndrome in Women." Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, vol. 32, no. 3, 2012, pp. 217-21.
Allahdin S, Oo N. An overview of treatment of overactive bladder syndrome in women. J Obstet Gynaecol. 2012;32(3):217-21.
Allahdin, S., & Oo, N. (2012). An overview of treatment of overactive bladder syndrome in women. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 32(3), 217-21. https://doi.org/10.3109/01443615.2011.649317
Allahdin S, Oo N. An Overview of Treatment of Overactive Bladder Syndrome in Women. J Obstet Gynaecol. 2012;32(3):217-21. PubMed PMID: 22369391.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - An overview of treatment of overactive bladder syndrome in women. AU - Allahdin,S, AU - Oo,N, PY - 2012/2/29/entrez PY - 2012/3/1/pubmed PY - 2012/7/28/medline SP - 217 EP - 21 JF - Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology JO - J Obstet Gynaecol VL - 32 IS - 3 N2 - Overactive bladder syndrome (OAB) is a common, often under-reported and under-treated condition that significantly affects the quality of life (QoL) of the sufferer and is associated with enormous related costs. Treatments options for OAB include lifestyle modifications, behavioural therapy, pharmacotherapy, neuromodulation, Botulinum toxin therapy and surgical interventions. For this paper, the Embase, Cochrane and Medline databases were searched for studies relating to the treatment options for OAB with (urge urinary incontinence) UUI from 1975 to 2010. Studies were also obtained from references of published reviews. Search terms used for retrieval were: overactive bladder syndrome, urge urinary incontinence, anticholinergics, Botulinum toxin A, sacral neuromodulation and clam bladder augmentation. The aim of this paper is to provide an overview of the treatment options currently available for women with OAB. SN - 1364-6893 UR - https://www.unboundmedicine.com/medline/citation/22369391/An_overview_of_treatment_of_overactive_bladder_syndrome_in_women_ DB - PRIME DP - Unbound Medicine ER -